Progress in mesenchymal stem cells for treatment of atherosclerosis.
- Author:
Jiajia LIU
;
Yiting ZHANG
;
Hang PENG
;
Pengxia LIU
- Publication Type:Journal Article
- MeSH:
Animals;
Atherosclerosis;
therapy;
Cell Differentiation;
Cells, Cultured;
Endothelial Cells;
cytology;
Humans;
Mesenchymal Stem Cell Transplantation;
methods;
Mesenchymal Stromal Cells;
cytology
- From:
Chinese Journal of Biotechnology
2013;29(11):1538-1547
- CountryChina
- Language:Chinese
-
Abstract:
Atherosclerosis is an inflammatory disease. However, its etiology has not been yet fully elucidated. Endothelial dysfunction is currently considered to be one of the most important steps in the initiation of atherosclerosis. In addition, vascular smooth muscle cells, which are the main cellular component of de novo and in-stent restenosis lesions, play an important role in the development of atherosclerosis. Promoting the regeneration of endothelial cells and inhibiting the proliferation of smooth muscle cells are pivotal for the prevention and treatment of vascular injury. Recently, some studies have demonstrated that mesenchymal stem cells can home to the site of injury and differentiate into endothelial cells to repair damaged blood vessels. On the contrary, other researches have revealed that mesenchymal stem cells can differentiate into vascular smooth muscle cells that are involved in the development of restenosis. Here, we review the fundamental researches of mesenchymal stem cell therapy for atherosclerosis and address the perspectives of mesenchymal stem cells in atherosclerosis treatment.
